Universe Pharmaceuticals INC, known by its stock ticker as UPC, is an international bio-pharmaceutical company based out of Jiangxi Province, PRC (People’s Republic of China). Inc established in 2010, the company specializes in the field of traditional Chinese medicines and chemical-based medications that target various chronic and acute diseases.
UPC is committed to the development, manufacture, and commercialization of therapeutic products intended for a wide range of ailments, including diabetes, cardiovascular diseases, hypertension, chronic gastritis, and kidney diseases. The company's dedication to the bio-pharmaceutical field lies in its motto to improve and maintain the health of patients globally, making quality healthcare accessible for all.
One of UPC's flagship products is its Guben Yanling Pill, a traditional Chinese medication prescribed for chronic gastritis. Additionally, UPC is also known for its bestselling Yinqiao Jiedu Tablets, which is a widely recognized Chinese medicine for colds.
The company operates a state-of-the-art manufacturing facility spread over an area of approximately 97,607 square meters. It is equipped with advanced manufacturing machinery and cutting-edge technologies for drug production. In 2019, UPC was granted priority status by the National Medical Products Administration in China for its Xuezhikang Capsules, underlining the company’s strength in R&D and manufacturing.
UPC's philosophy of consistent innovation and a patient-centric approach is at the heart of its operations. The company maintains strict quality control measures in its production processes, ensuring that its products meet the highest safety and efficacy standards.
Moreover, the company is continually investing in research and development to produce new treatments and seek out potential candidates for product portfolio expansion. These research initiatives aim to develop advanced and effective therapies for chronic health conditions affecting the global population.
Furthermore, UPC manages an expansive distribution network, enabling it to reach a broad range of customers. Its presence is not limited to only China but extends to international markets as well. Striving for global impact, UPC intends to continue its growth trajectory and contribute significantly to global healthcare in the years to come.
Overall, Universe Pharmaceuticals Inc embodies a strong commitment to enhancing global health via its comprehensive portfolio of traditional and modern pharmaceutical products. It further intends to strengthen its position as a leading bio-pharmaceutical entity through ongoing R&D efforts and international expansions.